Clinical Trial Update: Effects of Dexmedetomidine on Inflammatory Cytokines in Patients With Aneurysmal Subarachnoid Hemorrhage [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating dexmedetomidine for effects on inflammatory cytokines in patients with aneurysmal subarachnoid hemorrhage was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage
• Subarachnoid Hemorrhage

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: University of Cincinnati | Conditions: Subarachnoid Hemorrhage, Aneurysmal | Phase 3 | Status: TERMINATED